GlassScriptPhysician profile
Gary Richard Walton
NPI 1902804784
$5,413.94
in general payments reported to CMS, 2019-2025
49 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,126 · 2020: $515 · 2021: $996 · 2022: $714 · 2023: $785 · 2024: $535 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,062.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $715.53 | 2019-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $466.29 | 2019-2025 | |
| Janssen Biotech, INC. | $418.46 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $408.10 | 2019-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $321.05 | 2021-2025 | Prolaris, Myrisk |
| Abbvie INC. | $248.50 | 2019-2025 | Botox |
| Teleflex LLC | $248.31 | 2024-2025 | Barrigel |
| Boston Scientific Corporation | $222.17 | 2019-2025 | Lithovue, General - Kidney Stone Disease, Spaceoar System |
| Endo Pharmaceuticals INC. | $215.08 | 2019-2022 | |
| Pfizer INC. | $202.30 | 2019-2025 | |
| Blue Earth Diagnostics | $191.27 | 2019-2023 | |
| Urogen Pharma, INC. | $141.80 | 2020-2024 | Jelmyto |
| Myovant Sciences INC. | $124.75 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $120.90 | 2023-2024 | Orgovyx, Gemtesa |
| Astrazeneca Pharmaceuticals LP | $113.21 | 2021-2023 | Lynparza |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Walton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.